✨ Unlock Data Exports And Disclosure Access.Start Your 30-Day Free Trial Today →

Iovance Biotherapeutics Inc

Common Name
Iovance Biotherapeutics
Country
United States
Sector
Healthcare
Industry
Biotechnology
Employees
975
Ticker
IOVA
Exchange
NASDAQ/NMS
Description
Iovance Biotherapeutics is a commercial-stage biopharmaceutical company pioneering the development and commercialization of tumor-infiltrating lymphocyte (TIL) cell therapies for patients with solid t...

Disclosures of Iovance Biotherapeutics

Explore Iovance Biotherapeutics's complete collection of publicly available corporate disclosures, including annual reports, sustainability reports, financial statements, ESG data spreadsheets, and related web publications. Each document is sourced directly from Iovance Biotherapeutics's official channels and fully traceable to its official company sources.

The table below lists all of Iovance Biotherapeutics's' corporate disclosure by name and reporting period, ensuring full transparency and easy access.

Fiscal Year / TypeLanguages
20241 disclosure
Annual Report
en
20231 disclosure
10-K
en
20221 disclosure
10-K
en
20211 disclosure
10-K
en
20201 disclosure
10-K
en
20191 disclosure
10-K
en
20181 disclosure
10-K
en
20171 disclosure
10-K
en
20161 disclosure
10-K
en
20151 disclosure
10-K
en
Real-Time Disclosures Datafeed

Get Notified Within Seconds of New Corporate Disclosures

Tracenable is building a high-speed disclosure monitoring system that delivers instant alerts when companies publish new reports or data. Could a real-time datafeed (via SFTP, RSS or API) enhance your investment or analytical workflows?